A. Gasser Elizabeth's most recent trade in Tandem Diabetes Care Inc was a trade of 23,002 Restricted Stock Unit done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 23,002 | 23,002 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 23,000 | 23,000 | - | - | Performance Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 11,200 | 22,949 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 11,200 | 0 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,387 | 13,550 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,387 | 8,774 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.70 per share. | 15 May 2025 | 2,350 | 11,200 (0%) | 0% | 22.7 | 53,345 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,503 | 6,012 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,503 | 9,968 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 15.64 per share. | 15 May 2025 | 1,147 | 8,170 (0%) | 0% | 15.6 | 17,939 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.70 per share. | 15 May 2025 | 805 | 9,163 (0%) | 0% | 22.7 | 18,274 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 474 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 474 | 8,719 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.70 per share. | 15 May 2025 | 254 | 8,465 (0%) | 0% | 22.7 | 5,766 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 162 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 162 | 8,332 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.70 per share. | 15 May 2025 | 87 | 8,245 (0%) | 0% | 22.7 | 1,975 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2025 | 5,523 | 10,032 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2025 | 5,523 | 0 | - | - | Performance Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.34 per share. | 25 Feb 2025 | 3,009 | 7,023 (0%) | 0% | 33.3 | 100,320 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2025 | 1,380 | 5,248 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2025 | 1,380 | 0 | - | - | Performance Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.34 per share. | 25 Feb 2025 | 739 | 4,509 (0%) | 0% | 33.3 | 24,638 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,504 | 4,754 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,504 | 7,515 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.47 per share. | 18 Feb 2025 | 886 | 3,868 (0%) | 0% | 33.5 | 29,654 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 474 | 3,529 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 474 | 474 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.47 per share. | 18 Feb 2025 | 279 | 3,250 (0%) | 0% | 33.5 | 9,338 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 163 | 3,151 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 163 | 162 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.47 per share. | 18 Feb 2025 | 96 | 3,055 (0%) | 0% | 33.5 | 3,213 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,503 | 9,019 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,503 | 2,877 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.34 per share. | 15 Nov 2024 | 804 | 2,073 (0%) | 0% | 27.3 | 21,981 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 15.64 per share. | 15 Nov 2024 | 619 | 2,988 (0%) | 0% | 15.6 | 9,681 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 475 | 948 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 475 | 2,548 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.34 per share. | 15 Nov 2024 | 254 | 2,294 (0%) | 0% | 27.3 | 6,944 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 162 | 2,456 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 162 | 325 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.34 per share. | 15 Nov 2024 | 87 | 2,369 (0%) | 0% | 27.3 | 2,379 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,503 | 1,911 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,503 | 10,522 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.82 per share. | 15 Aug 2024 | 537 | 1,374 (0%) | 0% | 43.8 | 23,531 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 474 | 578 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 474 | 1,423 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.82 per share. | 15 Aug 2024 | 170 | 408 (0%) | 0% | 43.8 | 7,449 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 163 | 487 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 163 | 163 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.81 per share. | 15 Aug 2024 | 59 | 104 (0%) | 0% | 43.8 | 2,585 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 10 Jun 2024 | 11,749 | 0 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 10 Jun 2024 | 11,749 | 11,749 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 13,161 | 13,161 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 13,160 | 13,160 | - | - | Performance Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 373 | 11,883 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 373 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.73 per share. | 23 May 2024 | 134 | 11,749 (0%) | 0% | 51.7 | 6,932 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,012 | 12,025 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,012 | 13,656 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.37 per share. | 15 May 2024 | 2,146 | 11,510 (0%) | 0% | 47.4 | 101,656 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 15.64 per share. | 15 May 2024 | 813 | 7,236 (0%) | 0% | 15.6 | 12,715 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 474 | 1,897 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 474 | 7,814 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.37 per share. | 15 May 2024 | 170 | 7,644 (0%) | 0% | 47.4 | 8,053 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 162 | 650 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 162 | 7,398 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.36 per share. | 15 May 2024 | 58 | 7,340 (0%) | 0% | 47.4 | 2,747 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth Gasser A. | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 372 | 6,553 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | A. Gasser Elizabeth | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 372 | 373 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.34 per share. | 27 Feb 2024 | 130 | 6,423 (0%) | 0% | 27.3 | 3,554 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 475 | 2,371 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | A. Gasser Elizabeth | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 475 | 6,376 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Gasser Elizabeth A. | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.29 per share. | 15 Feb 2024 | 195 | 6,181 (0%) | 0% | 24.3 | 4,737 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth Gasser A. | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 163 | 5,968 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Gasser A. Elizabeth | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 163 | 812 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | A. Gasser Elizabeth | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 15 Feb 2024 | 67 | 5,901 (0%) | 0% | 24.3 | 1,627 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 372 | 1,118 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 372 | 4,710 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.06 per share. | 28 Aug 2023 | 129 | 4,581 (0%) | 0% | 27.1 | 3,491 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 474 | 3,320 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 474 | 4,502 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 15 Aug 2023 | 164 | 4,338 (0%) | 0% | 28.9 | 4,736 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 162 | 1,137 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 162 | 4,085 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 15 Aug 2023 | 57 | 4,028 (0%) | 0% | 28.9 | 1,646 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 18,037 | 18,037 | - | - | RSU 2023 05 25 | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 8,883 | 8,883 | - | - | PSU 2023 05 25 | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 373 | 4,052 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 373 | 1,490 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.57 per share. | 25 May 2023 | 129 | 3,923 (0%) | 0% | 26.6 | 3,428 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,897 | 3,794 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,897 | 4,335 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 15 May 2023 | 656 | 3,679 (0%) | 0% | 32.1 | 21,077 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 163 | 1,299 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 163 | 2,495 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.12 per share. | 15 May 2023 | 57 | 2,438 (0%) | 0% | 32.1 | 1,831 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 373 | 1,863 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 373 | 2,485 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.87 per share. | 27 Feb 2023 | 153 | 2,332 (0%) | 0% | 35.9 | 5,488 | Common Stock |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 162 | 2,179 (0%) | 0% | 0 | Common Stock |